NIH Posts Reminder of Its Policy on Application Compliance
The National Institutes of Health (NIH) recently released a notice to remind applicants, both investigators and grants office officials, that to be fair to all concerned the NIH needs to consistently apply standards for application compliance.
In part, the notice states that NIH may withdraw any application identified during the receipt, referral and review process that is not compliant with the instructions in the SF 424 (R&R) Application Guide, the Funding Opportunity Announcement, and relevant NIH Guide Notices.
Examples of reasons an application may be withdrawn for non-compliance include:
Read the full notice at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-095.html.
- inclusion of biosketchs that do not conform to the required format
- applications that do not conform to page limit requirements
- applications submitted as new but containing elements of a resubmission or renewal application
- applications submitted after 5 pm local time
Limited Submission Reminder: W.M. Keck Foundation Research Program
Key Deadlines: June 15, 2015 (CWRU internal LOI), November 1, 2015 (Sponsor Deadline).
The W.M. Keck Foundation Research Program seeks to benefit humanity by funding fundamental, high-risk research in two specific areas: 1) medical research and 2) science and engineering. Both Senior and Early Career investigators are encouraged to apply. CWRU may submit two proposals per funding cycle: one (1) in Medical Research and one (1) in Science and Engineering Research.
Applicants are encouraged to consult with their Associate Deans for Research prior to internal submission to assure they meet eligibility criteria and their projects meet stated program objectives.
Grants of up to $1 million over 3 years are awarded for projects in science and engineering research and medical research that:
- Focus on basic, early stage, emerging areas of research, not on clinical or translational research, treatment trials or research for the sole purpose of drug development.
- Have the potential to develop breakthrough technologies, instrumentation or methodologies.
- Have few, if any, peer groups pursuing comparable or related work.
- Have high level of risk due to unconventional approaches, or by challenging the prevailing paradigm.
- Have the potential for transformative impact, such as the founding of a new field of research, the enabling of observations not previously possible, or the altered perception of a previously intractable problem.
- Fall outside the mission of public funding agencies. Provide specifics. If you've been declined federal funding, provide the documentation stating why, if available.
- Demonstrate that the W. M. Keck Foundation's support is essential to the project's success.
For more information on this limited submission opportunity, visit the Office of Research Administration website.
Department of Defense
The Department of Defense has announced the following new funding opportunities:
Department of the Army - USAMRAA
DoD Gulf War Illness Innovative Treatment Evaluation Award
DoD Gulf War Illness Clinical Trial Award
DoD Gulf War Illness Epidemiology Research Award
DoD Gulf War Illness Investigator-Initiated Research Award
DoD Gulf War Illness New Investigator Research Award
NIH Center for Accelerated Innovations at Cleveland Clinic
The NIH Center for Accelerated Innovation at Cleveland Clinic (NCAI-CC) Announces the Request for Applications (RFA) for the third funding cycle for Cleveland Clinic, Case Western Reserve University, The Ohio State University, Cincinnati Children’s Hospital, and University of Cincinnati.
Funding is available for promising emerging technologies directed towards diagnosis, treatment or management of cardiovascular, pulmonary, blood or sleep-related disorders. We are seeking projects such as therapeutics (e.g. drugs, biologics), preventatives, diagnostics, devices, tools, etc., in order to facilitate their translation to commercialized products that improve patient care and enhance health.
The NCAI-CC will provide funding and project assistance to advance the development of high priority early-stage technologies within the mission areas of the NHLBI (cardiovascular, lung, blood and sleep disorders).
Expert assistance will be provided in areas required for early technology development, including commercial opportunity assessment, intellectual property, clinical and regulatory, reimbursement, business, legal and project management.
Letter of Intent Deadline: August 19, 2015
For more information visit the NCAI-CC webpage.
Purchasing Computing Devices with Federal Funds under the New Uniform Guidance (2 CFR Parts 200.20 and 200.453)
Computing devices are machines used to acquire, store, analyze, process, and publish data and other information electronically and include accessories (or peripherals) for printing, transmitting and receiving, or storing electronic information. Computing devices costing less than $5,000 are not considered equipment and therefore are treated as supplies and materials. Therefore, if a computing device is to be acquired for use in the performance of a federal award, the computing device may be charged to the federal award provided that:
Determining whether a computing device is essential – The Principal Investigator should consider (and document) whether performing the work under the award without the computing device would be difficult and inefficient. An important measure of this is determining (and documenting) whether the anticipated cost of performing the work without the computing device is greater than the combined cost of performing the work plus the cost of acquiring the computing device.
- it is essential (i.e., necessary) to performing the work under the award, and
- the cost is allocable and reasonable.
Determining whether a computing device is allocable to a federal award – If a computing device is essential to and will benefit a federal award, it is allocable to that award. The cost may be allocated to a federal award even when its usage is not solely dedicated to it. However, the Principal Investigator should first consider the amount of benefit of the computing device to the project, and the cost should be allocated proportionally with a reasonable cost allocation methodology.
Determining whether the cost of a computing device is reasonable – The Principal Investigator must make an informed, prudent decision, taking into consideration not only the cost, but the utility, quality and value of the device to the project.
If a computing device is not essential to a federal award, it is not allocable (in whole or in part) as a direct cost to that award. In such cases, the computing device is considered to be a “general use” item and must be treated as an indirect cost expense (just like paper, pens and other general use supplies), and charged to an appropriate institutional funding source.
Please remember that all expenses charged to federal awards must conform to the cost principles specified in the OMB Uniform Guidance. Please consult with the Office of Research Administration if you should have any questions about whether you may charge a specific expense to federal funds.
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
firstname.lastname@example.org no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be